Exploring the frequency of a TP53 polyadenylation signal variant in tumor DNA from patients diagnosed with lung adenocarcinomas, sarcomas and uterine leiomyomas-Reference-Cited by-同舟云学术

Exploring the frequency of a TP53 polyadenylation signal variant in tumor DNA from patients diagnosed with lung adenocarcinomas, sarcomas and uterine leiomyomas

Published:2023 Issue:3 suppl 1 Volume:46 Page:
ISSN:1678-4685
Container-title:Genetics and Molecular Biology
language:
Short-container-title:Genet. Mol. Biol.

Author:

Vieira Igor Araujo¹^ORCID,Viola Guilherme Danielski²,Pezzi Eduarda Heidrich³,Kowalski Thayne Woycinck⁴,Fernandes Bruna Vieira³,Andreis Tiago Finger²,Bom Natascha⁵,Sonnenstrahl Giulianna⁵,Rocha Yasminne Marinho de Araújo³,Corrêa Bruno da Silveira³^ORCID,Donatti Luiza Mezzomo⁶,Sant’Anna Gabriela dos Santos⁷,Corleta Helena von Eye⁸,Brum Ilma Simoni⁶,Rosset Clévia⁹^ORCID,Vianna Fernanda Sales Luiz¹⁰^ORCID,Macedo Gabriel S.¹¹,Palmero Edenir Inez¹²^ORCID,Ashton-Prolla Patricia¹³^ORCID

Affiliation:

1. Universidade Federal do Rio Grande do Sul, Brazil; Hospital de Clínicas de Porto Alegre, Brazil; Universidade do Vale do Rio dos Sinos, Brazil

2. Universidade Federal do Rio Grande do Sul, Brazil; Hospital de Clínicas de Porto Alegre, Brazil

3. Hospital de Clínicas de Porto Alegre, Brazil

4. Universidade Federal do Rio Grande do Sul, Brazil; Hospital de Clínicas de Porto Alegre, Brazil; Universidade Federal do Rio Grande do Sul, Brazil; Instituto Nacional de Genética Médica Populacional, Brazil; Hospital de Clínicas de Porto Alegre, Brazil; Complexo de Ensino Superior de Cachoeirinha, Brazil

5. Universidade do Vale do Rio dos Sinos, Brazil

6. Universidade Federal do Rio Grande do Sul, Brazil; Universidade Federal do Rio Grande do Sul, Brazil

7. Universidade Federal do Rio Grande do Sul, Brazil

8. Universidade Federal do Rio Grande do Sul, Brazil; Hospital de Clínicas de Porto Alegre, Brazil; Universidade Federal do Rio Grande do Sul, Brazil

9. Hospital de Clínicas de Porto Alegre, Brazil; Universidade Federal do Rio Grande do Sul, Brazil; Hospital de Clínicas de Porto Alegre, Brazil

10. Universidade Federal do Rio Grande do Sul, Brazil; Hospital de Clínicas de Porto Alegre, Brazil; Universidade Federal do Rio Grande do Sul, Brazil; Instituto Nacional de Genética Médica Populacional, Brazil; Hospital de Clínicas de Porto Alegre, Brazil; Universidade Federal do Rio Grande do Sul, Brazil; Universidade Federal do Rio Grande do Sul, Brazil

11. Universidade Federal do Rio Grande do Sul, Brazil; Hospital de Clínicas de Porto Alegre, Brazil; Hospital de Clínicas de Porto Alegre, Brazil

12. Instituto Nacional de Câncer, Brazil; Hospital de Câncer de Barretos, Brazil

13. Universidade Federal do Rio Grande do Sul, Brazil; Hospital de Clínicas de Porto Alegre, Brazil; Universidade Federal do Rio Grande do Sul, Brazil; Hospital de Clínicas de Porto Alegre, Brazil; Hospital de Clínicas de Porto Alegre, Brazil

Publisher

FapUNIFESP (SciELO)

Link

http://www.scielo.br/scielo.php?script=sci_pdf&pid=S1415-47572023000600118&tlng=en

Reference32 articles.

1. Analysis of predictive biomarkers in patients with lung adenocarcinoma from southern Brazil reveals a distinct profile from other regions of the country;Andreis TF;J Glob Oncol,2019

2. The impact of rare and low-frequency genetic variants in common disease;Bomba L;Genome Biol,2017

3. Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant;Deng Q;Nat Commun,2019

4. Heritable genetic variants in key cancer genes link cancer risk with anthropometric traits;Di Giovannantonio M;J Med Genet,2021

5. The dark matter of the cancer genome: Aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations;Diederichs S;EMBO Mol Med,2016